Jason Amello - Dec 8, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Financial Officer
Signature
/s/ Jason A. Amello
Stock symbol
CADL
Transactions as of
Dec 8, 2022
Transactions value $
$10,002
Form type
4
Date filed
12/12/2022, 03:25 PM
Previous filing
Nov 30, 2022
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $5.24K +3.1K $1.69 3.1K Dec 8, 2022 Direct F1
transaction CADL Common Stock Purchase $4.76K +2.47K +79.61% $1.93 5.57K Dec 9, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.